CXCL13 and melanoma: In melanoma patients, for example, intratumoral-tumor reactive T cells showed increased expression of exhaustion markers, reduced IFN-γ production and increased CXCL13 production compared to circulating tumour reactive T cells (as identified by tetramer staining) (20).